Clinical Trial Update: Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports on the safety and tolerability of enteric-coated mycophenolate sodium (EC-MPS) in renal transplant patients who experience gas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED